- ICH GCP
- US Clinical Trials Registry
- Search trials
Clinical Trials Sponsored by Jiangsu Kanion Pharmaceutical Co.,Ltd
Total 4682 results
-
Jiangsu HengRui Medicine Co., Ltd.Not yet recruitingPrimary Gout With Hyperuricemia in Adults
-
Jiangsu HengRui Medicine Co., Ltd.RecruitingNon-radiographic Axial SpondyloarthritisChina
-
Jiangsu HengRui Medicine Co., Ltd.RecruitingHepatocellular CarcinomaChina
-
Jiangsu HengRui Medicine Co., Ltd.Not yet recruitingAdvanced Malignant Tumor
-
Jiangsu HengRui Medicine Co., Ltd.Not yet recruitingImproved Glycemic Control in Patients With Type 2 Diabetes
-
Jiangsu HengRui Medicine Co., Ltd.Not yet recruiting
-
Jiangsu HengRui Medicine Co., Ltd.Not yet recruitingNasopharyngeal CarcinomaChina
-
Jiangsu HengRui Medicine Co., Ltd.RecruitingTreatment-naive Severe Aplastic AnemiaChina
-
Jiangsu HengRui Medicine Co., Ltd.RecruitingRecurrent and Refractory B-cell Non-Hodgkin's LymphomaChina
-
Jiangsu Alphamab Biopharmaceuticals Co., LtdRecruiting
-
Jiangsu HengRui Medicine Co., Ltd.Not yet recruiting
-
Jiangsu HengRui Medicine Co., Ltd.RecruitingImmune ThrombocytopeniaChina
-
Jiangsu HengRui Medicine Co., Ltd.RecruitingHepatic Impairment | Healthy ParticipantsChina
-
Jiangsu HengRui Medicine Co., Ltd.Recruiting
-
Jiangsu HengRui Medicine Co., Ltd.Recruiting
-
Jiangsu HengRui Medicine Co., Ltd.RecruitingRenal Cell Carcinoma | Cervical Cancer | Endometrial Cancer | Urothelial Carcinoma | Ovarian Cancer RecurrentChina
-
Jiangsu HengRui Medicine Co., Ltd.Recruiting
-
Jiangsu HengRui Medicine Co., Ltd.Completed
-
Jiangsu Alphamab Biopharmaceuticals Co., LtdActive, not recruitingAdvanced Pancreatic Ductal AdenocarcinomaChina
-
Jiangsu Alphamab Biopharmaceuticals Co., LtdCompletedGastric/Gastroesophageal Junction CancerChina
-
Jiangsu Rec-Biotechnology Co., Ltd.Completed
-
Jiangsu HengRui Medicine Co., Ltd.Terminated
-
Jiangsu HengRui Medicine Co., Ltd.Active, not recruiting
-
Jiangsu HengRui Medicine Co., Ltd.Completed
-
Jiangsu HengRui Medicine Co., Ltd.CompletedLocally Advanced or Metastatic and Unresectable HCCUnited States, Spain, China, Taiwan, Belgium, Korea, Republic of, Italy, Hong Kong, Russian Federation, Ukraine, Turkey, Poland, Germany
-
Jiangsu HengRui Medicine Co., Ltd.Completed
-
Jiangsu HengRui Medicine Co., Ltd.CompletedGastric Cancer | GastroEsophageal CancerChina
-
Jiangsu HengRui Medicine Co., Ltd.Active, not recruiting
-
Jiangsu HengRui Medicine Co., Ltd.CompletedGraft-versus-host DiseaseChina
-
Jiangsu HengRui Medicine Co., Ltd.Active, not recruitingAsthma With Eosinophilic PhenotypeChina
-
Jiangsu HengRui Medicine Co., Ltd.CompletedAdvanced MalignanciesAustralia, China
-
Jiangsu HengRui Medicine Co., Ltd.CompletedHormone Sensitive Prostate CancerChina
-
Jiangsu HengRui Medicine Co., Ltd.Active, not recruiting
-
Jiangsu HengRui Medicine Co., Ltd.CompletedSecond-line Treatment for Locally Advanced or Metastatic Pancreatic Cancer After Treatment Failure With Gemcitabine-based TherapyChina
-
Jiangsu HengRui Medicine Co., Ltd.CompletedModerate-to-severe Chronic Plaque PsoriasisUnited States, Australia, China
-
Jiangsu HengRui Medicine Co., Ltd.Completed
-
Jiangsu Alphamab Biopharmaceuticals Co., LtdTerminatedHER2-positive Metastatic Breast CancerChina
-
Jiangsu HengRui Medicine Co., Ltd.CompletedAdvanced Solid TumorChina
-
Jiangsu HengRui Medicine Co., Ltd.Terminated
-
Jiangsu HengRui Medicine Co., Ltd.Completed
-
Jiangsu HengRui Medicine Co., Ltd.CompletedPrimary Hypercholesterolemia | Mixed HyperlipemiaChina
-
Jiangsu HengRui Medicine Co., Ltd.Completed
-
Jiangsu HengRui Medicine Co., Ltd.TerminatedBreast Cancer | Triple Negative Breast CancerChina
-
Jiangsu HengRui Medicine Co., Ltd.Completed
-
Jiangsu Alphamab Biopharmaceuticals Co., LtdTerminatedAdvanced Non-small Cell Lung CancerChina
-
Jiangsu HengRui Medicine Co., Ltd.CompletedPrimary HypercholesterolemiaChina
-
Jiangsu HengRui Medicine Co., Ltd.Active, not recruiting
-
Jiangsu HengRui Medicine Co., Ltd.Completed
-
Jiangsu HengRui Medicine Co., Ltd.CompletedAdvanced Biliary Tract Carcinoma | Advanced Primary Liver CancerChina
-
Jiangsu HengRui Medicine Co., Ltd.CompletedSmall-cell Lung CancerChina